Jiangxi Synergy Pharmaceutical Co., Ltd. (SHE:300636)
China · Delayed Price · Currency is CNY 6.68
+0.07 (1.06%)
Jul 30, 2026, 3:04 PM CST
SHE:300636 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 826.15 | 828.66 | 758.89 | 722.14 | 719.91 | 592.13 |
Revenue Growth | 11.74% | 9.19% | 5.09% | 0.31% | 21.58% | 35.99% |
Gross Profit Gross Profit Growth | 188.87 | 187.78 | 219.51 | 220.36 | 226.07 | 171.28 |
Operating Income Operating Income Growth | 50.29 | 51.28 | 89.67 | 93.85 | 109.95 | 89.32 |
Net Income Net Income Growth | 71.09 | 73.09 | 106.58 | 105.98 | 100.67 | 81.12 |
Earnings Per Share EPS Growth | 0.17 | 0.17 | 0.25 | 0.28 | 0.29 | 0.24 |
EPS Growth | -15.22% | -31.44% | -8.90% | -4.20% | 21.02% | 6.19% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Pharmaceutical Manufacturing Pharmaceutical Manufacturing Growth | 822.55 | 825.05 | 757.93 | 720.7 | 718.59 | 589.07 |
Unallocated Other Operations Unallocated Other Operations Growth | - | 3.61 | 0.96 | 1.43 | 1.32 | 3.06 |
Total Total Growth | 826.15 | 828.66 | 758.89 | 722.14 | 719.91 | 592.13 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 274.41 | 808.05 | 391.02 | 577.24 | 141.96 | 161.29 |
Total Debt Total Debt Growth | 611.9 | 636.5 | 702.75 | 768.96 | 614.13 | 810.78 |
Net Cash (Debt) Net Cash Growth | -337.5 | 171.54 | -311.74 | -191.72 | -472.17 | -649.48 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.80 | 0.41 | -0.74 | -0.50 | -1.36 | -1.92 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 188.87 | 202.07 | 285.19 | 163.75 | 196 | 131.34 |
Capital Expenditures CapEx Growth | -282.43 | -291.24 | -136.49 | -214.65 | -311.49 | -424.67 |
Free Cash Flow Free Cash Flow Growth | -93.56 | -89.17 | 148.7 | -50.9 | -115.5 | -293.33 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Gross Margin | 22.86% | 22.66% | 28.93% | 30.51% | 31.40% | 28.93% |
Operating Margin | 6.09% | 6.19% | 11.82% | 13.00% | 15.27% | 15.09% |
Pretax Margin | 8.85% | 9.12% | 15.11% | 15.58% | 14.74% | 14.92% |
Profit Margin | 8.61% | 8.82% | 14.04% | 14.68% | 13.98% | 13.70% |
FCF Margin | -11.33% | -10.76% | 19.59% | -7.05% | -16.04% | -49.54% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.040 | 0.040 | 0.040 | 0.040 | 0.045 | 0.040 |
Dividend Per Share Growth | 0% | 0% | 0% | -11.11% | 12.50% | 12.99% |
Dividend Yield | 0.61% | 0.54% | 0.51% | 0.39% | 0.31% | 0.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 39.07 | 43.15 | 31.26 | 41.73 | 51.00 | 66.90 |
Forward PE | 30.74 | 25.03 | 19.68 | 33.46 | 36.12 | 43.57 |
P/FCF Ratio | - | - | 22.41 | - | - | - |
PS Ratio | 3.36 | 3.81 | 4.39 | 6.12 | 7.13 | 9.16 |